Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 32% ± 10% | |
lung | 16 studies | 32% ± 11% | |
brain | 13 studies | 29% ± 13% | |
kidney | 9 studies | 27% ± 7% | |
eye | 7 studies | 32% ± 12% | |
intestine | 6 studies | 28% ± 14% | |
bone marrow | 5 studies | 20% ± 4% | |
pancreas | 4 studies | 55% ± 22% | |
placenta | 4 studies | 27% ± 8% | |
uterus | 4 studies | 41% ± 14% | |
lymph node | 4 studies | 29% ± 10% | |
breast | 4 studies | 25% ± 1% | |
liver | 3 studies | 39% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5505.09 | 1445 / 1445 | 100% | 43.35 | 183 / 183 |
uterus | 100% | 7339.11 | 170 / 170 | 100% | 59.59 | 459 / 459 |
breast | 100% | 6535.32 | 459 / 459 | 100% | 81.15 | 1117 / 1118 |
kidney | 100% | 8189.13 | 89 / 89 | 100% | 78.07 | 900 / 901 |
thymus | 100% | 11237.48 | 653 / 653 | 100% | 91.95 | 604 / 605 |
lung | 100% | 7014.01 | 577 / 578 | 100% | 59.37 | 1155 / 1155 |
bladder | 100% | 5782.67 | 21 / 21 | 100% | 55.20 | 503 / 504 |
brain | 100% | 7455.90 | 2636 / 2642 | 100% | 69.01 | 705 / 705 |
prostate | 100% | 5119.64 | 245 / 245 | 100% | 46.58 | 500 / 502 |
ovary | 100% | 5631.81 | 180 / 180 | 100% | 46.34 | 428 / 430 |
intestine | 100% | 5660.62 | 966 / 966 | 99% | 47.37 | 523 / 527 |
skin | 100% | 8742.18 | 1809 / 1809 | 99% | 61.96 | 468 / 472 |
stomach | 99% | 3583.86 | 355 / 359 | 100% | 47.82 | 286 / 286 |
adrenal gland | 100% | 6085.40 | 258 / 258 | 98% | 64.35 | 226 / 230 |
liver | 98% | 2904.37 | 222 / 226 | 99% | 31.60 | 403 / 406 |
pancreas | 85% | 1783.17 | 279 / 328 | 99% | 53.38 | 176 / 178 |
adipose | 100% | 6993.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10218.09 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 45.16 | 29 / 29 |
spleen | 100% | 5176.74 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 55.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.75 | 1 / 1 |
peripheral blood | 95% | 4573.86 | 883 / 929 | 0% | 0 | 0 / 0 |
heart | 93% | 3037.97 | 805 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 31.13 | 74 / 80 |
muscle | 57% | 1002.63 | 460 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032914 | Biological process | positive regulation of transforming growth factor beta1 production |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0048388 | Biological process | endosomal lumen acidification |
GO_0007042 | Biological process | lysosomal lumen acidification |
GO_0051452 | Biological process | intracellular pH reduction |
GO_0097401 | Biological process | synaptic vesicle lumen acidification |
GO_0002003 | Biological process | angiotensin maturation |
GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
GO_0021903 | Biological process | rostrocaudal neural tube patterning |
GO_0048069 | Biological process | eye pigmentation |
GO_0007035 | Biological process | vacuolar acidification |
GO_0061795 | Biological process | Golgi lumen acidification |
GO_0021626 | Biological process | central nervous system maturation |
GO_0043408 | Biological process | regulation of MAPK cascade |
GO_0060323 | Biological process | head morphogenesis |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005764 | Cellular component | lysosome |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0033176 | Cellular component | proton-transporting V-type ATPase complex |
GO_0000139 | Cellular component | Golgi membrane |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0032591 | Cellular component | dendritic spine membrane |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0000220 | Cellular component | vacuolar proton-transporting V-type ATPase, V0 domain |
GO_0010008 | Cellular component | endosome membrane |
GO_0030424 | Cellular component | axon |
GO_0016471 | Cellular component | vacuolar proton-transporting V-type ATPase complex |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0030665 | Cellular component | clathrin-coated vesicle membrane |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ATP6AP2 |
Protein name | ATPase H+ transporting accessory protein 2 Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (Renin/prorenin receptor) Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (ATP6M8-9) (V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment] |
Synonyms | ATP6IP2 HT028 MSTP009 PSEC0072 ELDF10 CAPER |
Description | FUNCTION: Multifunctional protein which functions as a renin, prorenin cellular receptor and is involved in the assembly of the lysosomal proton-transporting V-type ATPase (V-ATPase) and the acidification of the endo-lysosomal system . May mediate renin-dependent cellular responses by activating ERK1 and ERK2 . By increasing the catalytic efficiency of renin in AGT/angiotensinogen conversion to angiotensin I, may also play a role in the renin-angiotensin system (RAS) . Through its function in V-type ATPase (v-ATPase) assembly and acidification of the lysosome it regulates protein degradation and may control different signaling pathways important for proper brain development, synapse morphology and synaptic transmission (By similarity). . |
Accessions | O75787 ENST00000447485.6 A0A1B0GVZ1 ENST00000637482.1 A0A1B0GTU8 A0A1B0GVW0 ENST00000436783.6 A0A1B0GVI9 A0A1B0GWD6 A0A1B0GU12 H7C240 A0A1B0GTD6 ENST00000636251.1 A0A1B0GVB9 ENST00000636574.1 A0A1B0GWJ8 H7C3E1 B7Z1I9 ENST00000423649.2 ENST00000637526.1 A0A1B0GV24 ENST00000635774.1 ENST00000636580.2 [O75787-1] ENST00000636287.1 ENST00000378438.9 ENST00000635734.1 B7Z413 A0A1B0GV60 ENST00000638153.1 ENST00000636787.1 A0A1B0GTB0 A0A1B0GW13 A0A1C7CYW4 ENST00000636196.1 A0A1B0GUV3 ENST00000636639.1 A0A1B0GUT7 ENST00000637955.1 A0A1B0GVC7 ENST00000636970.1 ENST00000486558.6 ENST00000637614.1 ENST00000636409.1 [O75787-2] ENST00000637165.1 ENST00000637327.1 |